Evome Medical Technologies Inc.
EVMT.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.31M | -14.24M | -13.40M | -11.45M | -3.54M |
| Total Depreciation and Amortization | 1.37M | 2.53M | 1.93M | 1.86M | 2.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.44M | 12.62M | 9.76M | 9.61M | 1.96M |
| Change in Net Operating Assets | 3.45M | 841.50K | 1.17M | -697.90K | -1.29M |
| Cash from Operations | 3.95M | 1.75M | -536.50K | -691.60K | -383.70K |
| Capital Expenditure | -26.70K | -110.80K | -110.80K | -151.20K | -594.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -980.80K | -980.80K | -980.80K | -1.68M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -40.20K |
| Cash from Investing | -26.70K | -1.09M | -1.09M | -1.13M | -2.31M |
| Total Debt Issued | -197.80K | -1.85M | -1.97M | 949.10K | 649.50K |
| Total Debt Repaid | -5.88M | -2.77M | -35.40K | -158.50K | -920.90K |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 33.90K | 33.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -4.22M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 1.24M |
| Cash from Financing | -4.45M | -3.39M | -1.48M | 615.00K | -2.36M |
| Foreign Exchange rate Adjustments | 784.20K | 769.30K | 529.10K | 446.30K | 177.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.20K | -1.96M | -2.58M | -762.50K | -4.88M |